
ACT Brief: China’s Startup Timelines, AI-Drafted Clinical Study Reports, and Bimzelx Psoriatic Arthritis Data
2026-11-10
0:00
1:47
In today’s ACT Brief, we examine how China’s trial startup timelines compare with those in the US and Europe, whether AI-drafted clinical study reports speed drug development, and how Bimzelx compared with Skyrizi in psoriatic arthritis.
Fler avsnitt från "Applied Clinical Trials"



Missa inte ett avsnitt av “Applied Clinical Trials” och prenumerera på det i GetPodcast-appen.








